SNHG6 is significantly upregulated in hepatoma compared to normal liver tissue and has been shown to be a cholesterol effector that accelerates progression from non-alcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). Here, SNHG6 is linked to hepatocellular carcinoma.